PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.54%
Net income growth 1.25-1.5x MRVL's 10.34%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
5.61%
D&A growth well above MRVL's 4.30%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-7.74%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
14.05%
SBC growth well above MRVL's 13.48%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-299.04%
Both reduce yoy usage, with MRVL at -75.68%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
25.32%
AR growth while MRVL is negative at -174.34%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-39.17%
Both reduce yoy inventory, with MRVL at -76.29%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
3840.91%
AP growth well above MRVL's 259.69%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-97.71%
Negative yoy usage while MRVL is 159.52%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-107.38%
Both negative yoy, with MRVL at -97.90%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-5.58%
Both yoy CFO lines are negative, with MRVL at -5.58%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-164.77%
Negative yoy CapEx while MRVL is 41.96%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-612.82%
Negative yoy acquisition while MRVL stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
39.14%
Purchases growth of 39.14% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-1.06%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
94.44%
Less 'other investing' outflow yoy vs. MRVL's 209.09%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
44.07%
Investing outflow well above MRVL's 47.99%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.52%
We have some buyback growth while MRVL is negative at -16.67%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.